Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs (Q73076505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

M Bialer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

187-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Can we develop improved derivatives of valproic acid?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Clinical pharmacology of valpromide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Disposition of two tetramethylcyclopropane analogues of valpromide in the brain, liver, plasma and urine of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

The disposition of valproyl glycinamide and valproyl glycine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Antiepileptic Drug Development Program

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900037-1

7 January 2021

10.1016/S0168-3659(99)00037-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518650%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference